Altogether, our study reports a novel role of LPS in driving S100A7 expression for modulating the expression of TLR4 and RAGE, which demands further exploration of this regulatory axis for drug intervention of invasive breast cancers. Here, S100A7 is linked to invasive breast carcinoma.